AVXL
Anavex Life Sciences Corp
2.50$
+2.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +210.2% | +219.3% | +47.1% | +25.0% | +66.8% | +13.3% | +30.7% | +15.0% | +15.3% | -4.3% | -10.1% | |
| – | +116.3% | +72.3% | -39.9% | +19.6% | +14.3% | -14.5% | +54.0% | +44.9% | -7.9% | -8.3% | +25.2% | |
| – | +139.4% | +109.3% | +4.5% | +23.5% | +50.2% | +7.9% | +35.1% | +21.4% | +9.4% | -5.2% | -2.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +913.2% | +15,663.3% | -100.0% | – | +388.4% | +3,080.0% | -16.0% | -76.6% | +1.8% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +913.2% | -58.8% | +101.3% | +22.0% | +13.0% | -5,396.1% | – | +33.6% | -102.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.